Skip to main content
. Author manuscript; available in PMC: 2014 Apr 9.
Published in final edited form as: Leukemia. 2012 Jun 5;26(11):2428–2431. doi: 10.1038/leu.2012.153

Figure 1.

Figure 1

(A–C) Kaplan-Meier estimates for 45 patients, including 25 patients on the CC arm and 20 patients on the DAC arm of (A) OS, (B) EFS and (C) incidence of relapse are shown. There was no significant difference noted between the group (P-values of 0.9, 0.9 and 0.7, respectively). (D–F) Kaplan-Meier estimates for MFC for 38 patients, including 30 patients with negative and 8 patients with positive MFC at the time of study entry. (D) OS, (E) EFS and (F) Cumulative incidence of relapse are shown. There was significant difference between the groups (P-values of p = 0.002, p < 0.0001 and p < 0.0001, respectively, by log-rank test).